ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.68
-1.17%
US Tech 100
16,918.80
-2.26%
S&P 500
5,035.69
-1.57%
US Dollar vs CAD
1.37776
0.00%
Bitcoin
60,018.28
-0.96%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. PharmaCyte Biotech Inc (PMCB)

  7. PharmaCyte Biotech Inc (PMCB) News

PMCB PharmaCyte Biotech Inc

2.12
0.00 (0.00%)
Apr 30 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
PharmaCyte Biotech Inc PMCB NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 2.12 15:55:32
Open Price Low Price High Price Close Price Previous Close
2.12 2.12 2.20 2.12 2.12
more quote information »

Recent News

Date Time Source Heading
2/14/202414:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/06/202408:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/15/202316:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/28/202316:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/24/202315:00EDGAR2Form 8-K - Current report
11/22/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202315:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
11/15/202307:30BWPharmaCyte Biotech Acquires $5 Million Stake in Emerging..
11/09/202316:25EDGAR2Form 8-K - Current report
10/31/202308:15BWPharmaCyte Biotech Provides Corporate Update on..
9/21/202316:04EDGAR2Form S-3/A - Registration statement under Securities Act of..
9/18/202305:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
9/15/202316:00EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
9/11/202320:56EDGAR2Form S-3/A - Registration statement under Securities Act of..
9/07/202315:05EDGAR2Form 8-K - Current report
8/04/202315:40EDGAR2Form S-3/A - Registration statement under Securities Act of..
8/04/202315:01EDGAR2Form 8-K - Current report
7/31/202316:18EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
7/31/202315:42EDGAR2Form DEF 14A - Other definitive proxy statements
7/19/202309:28EDGAR2Form PRE 14A - Other preliminary proxy statements
6/15/202308:15BWPharmaCyte Biotech Announces Final Results of Tender Offer
5/11/202307:30BWPharmaCyte Biotech Announces Cash Tender Offer for up to..

Your Recent History

NASDAQ
PMCB
PharmaCyte Biotech
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved